Featured Research

from universities, journals, and other organizations

Combined MMRV vaccine shows slight rise in febrile seizures in children, study shows

Date:
June 9, 2014
Source:
Canadian Medical Association Journal
Summary:
The combined measles-mumps-rubella-varicella (MMRV) vaccine shows a slightly increased risk of febrile seizures in children, compared with the previously separate vaccines for MMR and varicella (chickenpox) (MMR+V), according to an article. The MMRV vaccine was originally developed for young children to reduce the number of needles they receive.

The combined measles-mumps-rubella-varicella (MMRV) vaccine shows a slightly increased risk of febrile seizures in children, compared with the previously separate vaccines for MMR and varicella (chickenpox) (MMR+V), according to an article in CMAJ (Canadian Medical Association Journal).

The MMRV vaccine was developed for young children to reduce the number of needles they receive. However, the combined vaccine has been associated with slightly higher rates of febrile seizures.

Febrile seizures can accompany high fever in young children; although distressing, they are not associated with ongoing health issues.

"Combining MMR and varicella into a single vaccine decreases pain for children and distress for parents, thus addressing common barriers to vaccine uptake, and may improve vaccination coverage levels and decrease immunization delivery costs," writes Dr. Shannon MacDonald, Faculty of Medicine, University of Calgary.

"Febrile seizures are typically self-limiting and rarely have long-term effects, but they can be extremely distressing for parents, may precipitate acute care visits and may undermine confidence in immunization programs."

To determine whether there is an increased risk of febrile seizures from the combined vaccine, researchers looked at data on 227 774 children aged 12 to 23 months who received either the MMR+V or the MMRV vaccine between 2006 and 2012 in Alberta, Canada.

The researchers found a slight increase in the relative risk of febrile seizure with the MMRV vaccine compared with the MMR+V vaccine -- about 1 excess seizure for every 2841 doses administered in the 7- to 10-day period after vaccination. Although this rate is double that for the MMR+V vaccine, the absolute risk is relatively small. The researchers suggest counselling parents about the risk of fever and to use children's fever medication to alleviate symptoms.

Two versions of MMRV are used in North America. Canada uses the Priorix-Tetra formulation, as does Australia, Italy and Germany; the United States uses ProQuad. Priorix-Tetra is also approved for use in many member states of the European Union.

This study's findings are consistent with the results of a study of the US version of the vaccine.

"It is a matter for debate whether the choice of separate versus combination vaccine is a policy decision or a choice for parents to make in consultation with their vaccination provider," the authors conclude.


Story Source:

The above story is based on materials provided by Canadian Medical Association Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. Shannon E. Macdonald, Douglas C. Dover, Kimberley A. Simmonds, Lawrence W. Svenson. Risk of febrile seizures after first dose of measles–mumps–rubella–varicella vaccine: a population-based cohort study. CMAJ, June 2014 DOI: 10.1503/cmaj.140078

Cite This Page:

Canadian Medical Association Journal. "Combined MMRV vaccine shows slight rise in febrile seizures in children, study shows." ScienceDaily. ScienceDaily, 9 June 2014. <www.sciencedaily.com/releases/2014/06/140609122048.htm>.
Canadian Medical Association Journal. (2014, June 9). Combined MMRV vaccine shows slight rise in febrile seizures in children, study shows. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2014/06/140609122048.htm
Canadian Medical Association Journal. "Combined MMRV vaccine shows slight rise in febrile seizures in children, study shows." ScienceDaily. www.sciencedaily.com/releases/2014/06/140609122048.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins